Stephanie• July 27, 2018• News
August 15, 2022• News
Affordable Drugs NOW Brian Frosh Drug Cost Commission Prescription Drug Affordability Initiative prescription drugs price gouging
Last modified: July 27, 2018
Comments are closed.
211 2021 General Assembly AARP Maryland ACA ACA Affordable Care Act Adam Jones Affordable Care Act affordable prescriptions Alcohol Alcohol sales tax Alcohol tax Angela Alsobrooks Annapolis Attorney General Brian Frosh Baltimore Sun Barry Glassman Brian Frosh Bruce DePuyt Calvin Ball Carolyn Quattrocki Daily Record Delegate Erek Barron Delegate Jazz Lewis Delegate Joseline Peña-Melnyk Developmental Disabilities Dr. Leana Wen Drug Cost Commission Easy Enrollment Eddie Murray Exchange faith Fox 45 Gov. Larry Hogan Governor Larry Hogan health care healthcare health care enrollment Health Care Workforce Development Health Enterprise Zones Health Equity Resource Communities health insurance Health Insurance Down Payment Health Reform Healthy Maryland Initiative House Speaker Adrienne Jones Howard County Individual Mandate Johnny Olszewski Larry Zarzecki Lorraine Sheehan Health and Community Services Act Marc Elrich Maryland Maryland Citizens Health Initiative Maryland Easy Enrollment Health Insurance Program Maryland General Assembly Maryland Health Benefit Exchange Maryland Health Connection Maryland Matters Maryland NAACP Matthew Celentano media advisory Medicaid Mental Health Michele Eberle Obamacare open enrollment OpinionWorks Peter Franchot PHARMA Prescription Drug Prescription Drug Affordability Prescription Drug Affordability Board Prescription Drug Affordability Initiative prescription drugs price gouging radio ad reinsurance Rep. Elijah Cummings Senator Antonio Hayes Senator Brian Feldman Senator Katherine Klausmeier Senator Kathy Klausmeier small business special enrollment period Stan Dorn Stephanie Klapper Steuart Pittman subsidies Substance Abuse Treatment Supreme Court Suzanne Schlattman tax credits Tobacco tobacco tax Van Mitchell Vincent DeMarco Washington Post WBAL WJZ WYPR
